Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration

机译：玻璃体内贝伐单抗与贝伐单抗和曲安奈德联合治疗新血管性年龄相关性黄斑变性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo compare the short-term outcomes of intravitreal bevacizumab (IVB) with the combination of IVB and intravitreal triamcinolone acetonide (IVB/IVT) for treatment of neovascular age-related macular degeneration (AMD).

机译：目的比较玻璃体内贝伐单抗（IVB）与玻璃体腔注射曲安奈德（IVB / IVT）联合治疗新生血管性年龄相关性黄斑变性（AMD）的近期疗效。

著录项

期刊名称 Journal of Ophthalmic Vision Research
作者
Mohammad Riazi-Esfahani; Hamid Ahmadieh; Hooshang Faghihi; Niloofar Piri; Ramin Taei; Reza Karkhaneh; Zahra Alami-Harandi; Alireza Lashay; Ahmad Mirshahi; Mehdi Nili-Ahmadabadi; Masoud Soheilian; Masoumeh Sanagou;
展开▼
作者单位

展开▼
年(卷),期 2008(3),2
年度 2008
页码 95–101
总页数 7
原文格式 PDF
正文语种
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial. [J] . Ahmadieh H, Taei R, Riazi Esfahani M, Retina . 2011,第9期

机译：玻璃体内贝伐单抗与玻璃体内贝伐单抗联合曲安奈德治疗与年龄相关的新血管性黄斑变性：一项随机临床试验的六个月结果。
2. A retrospective analysis of triple combination therapy with intravitreal bevacizumab, posterior sub-tenon's triamcinolone acetonide, and low-fluence verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration. [J] . Kovacs KD, Quirk MT, Kinoshita T, Retina . 2011,第3期

机译：对新生血管性黄斑变性患者三联联合玻璃体内注射贝伐单抗，后腱下曲安奈德和低通量维替泊芬光动力疗法的回顾性分析。
3. Intravitreal Bevacizumab and Triamcinolone Acetonide Combination Therapy for Exudative Neovascular Age-Related Macular Degeneration: Short-Term Optical Coherence Tomography Results [J] . Michael Colucciello Journal of Ocular Pharmacology and Therapeutics . 2008,第1期

机译：玻璃体腔注射贝伐单抗和曲安奈德联合治疗渗出性新血管性年龄相关性黄斑变性：短期光学相干断层扫描结果
4. Bevacizumab (Avastin) conjugated microbubbles for anti-VEGF treatment of neovascular age-related macular degeneration [C] . Leilei Zhang, Jeff Xu, Jiwei Huang, Conference on ophthalmic technologies . 2010

机译：贝伐单抗（Avastin）缀合的微泡用于抗VEGF治疗新生血管性年龄相关性黄斑变性
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration [O] . Hamid Ahmadieh, Ramin Taei, Masoud Soheilian, 2007

机译：单次光动力疗法联合玻璃体内贝伐单抗和曲安西龙治疗新生血管性年龄相关性黄斑变性
7. Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study [O] . Weigert, G, Michels, S, Sacu, S, 2008

机译：玻璃体内贝伐单抗（Avastin）与光动力疗法联合玻璃体内曲安西龙治疗与年龄相关的新生血管性黄斑变性：前瞻性，随机对照临床研究的6个月结果

Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration

摘要

著录项

相似文献

相关主题

期刊订阅